Charles McNerney, general manager of retail technology at Microsoft, has been appointed to the board of directors of Nativis, Inc., a Seattle-based clinical stage bio-electronic company. The company uses precisely targeted, ultra-low radio frequency energy (ulRFE) to regulate metabolic pathways on the molecular and genetic levels. The technology is delivered via a simple-to-use non-invasive device called Nativi. (Watch the video below for an explanation of the technology.)”]